Literature DB >> 11819589

Treatment of Helicobactor pylori infection: analysis of Chinese clinical trials.

Yu-Yuan Li, Wei-Hong Sha.   

Abstract

Year:  2000        PMID： 11819589      PMCID： PMC4688743          DOI： 10.3748/wjg.v6.i3.324

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  6 in total

Review 1.  Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.

Authors: 
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori.

Authors:  N Chiba; B V Rao; J W Rademaker; R H Hunt
Journal:  Am J Gastroenterol       Date:  1992-12       Impact factor: 10.864

3.  [Clarithromycin combined short-term triple therapies for eradication of Helicobacter pylori infection].

Authors:  W Liu; B Lü; S Xiao
Journal:  Zhonghua Nei Ke Za Zhi       Date:  1996-12

4.  [Omeprazole, clarithromycin and amoxicillin therapy for Helicobacter pylori infection].

Authors:  S Chen; Z Chen; L Bei
Journal:  Zhonghua Nei Ke Za Zhi       Date:  1996-12

Review 5.  Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection.

Authors:  S K Lam; N J Talley
Journal:  J Gastroenterol Hepatol       Date:  1998-01       Impact factor: 4.029

Review 6.  For what conditions is there evidence-based justification for treatment of Helicobacter pylori infection?

Authors:  C W Howden
Journal:  Gastroenterology       Date:  1997-12       Impact factor: 22.682
  6 in total
  1 in total

1.  Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy.

Authors:  Lian Zhang; Lin Shen; Jun-Ling Ma; Kai-Feng Pan; Wei-Dong Liu; Jie Li; Shu-Dong Xiao; San-Ren Lin; Meinhard Classen; Wei-Cheng You
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.